These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 15778354)

  • 1. Ex vivo characterization of the autoimmune T cell response in the HLA-DR1 mouse model of collagen-induced arthritis reveals long-term activation of type II collagen-specific cells and their presence in arthritic joints.
    Latham KA; Whittington KB; Zhou R; Qian Z; Rosloniec EF
    J Immunol; 2005 Apr; 174(7):3978-85. PubMed ID: 15778354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An autoantigen-specific, highly restricted T cell repertoire infiltrates the arthritic joints of mice in an HLA-DR1 humanized mouse model of autoimmune arthritis.
    Qian Z; Latham KA; Whittington KB; Miller DC; Brand DD; Rosloniec EF
    J Immunol; 2010 Jul; 185(1):110-8. PubMed ID: 20511555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of inhibitory T cells induced by an analog of type II collagen in an HLA-DR1 humanized mouse model of autoimmune arthritis.
    Kimata M; Cullins DL; Brown ML; Brand DD; Rosloniec EF; Myers LK; Stuart JM; Kang AH
    Arthritis Res Ther; 2012 May; 14(3):R107. PubMed ID: 22569209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with TCR Vbeta10 peptide reduces the frequency of type-II collagen-specific Th1 type T cells in BUB/BnJ (H-2q) mice.
    Anthony DD; Heeger PS; Haqqi TM
    Clin Exp Rheumatol; 2001; 19(4):385-94. PubMed ID: 11491493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tracking of proinflammatory collagen-specific T cells in early and late collagen-induced arthritis in humanized mice.
    Svendsen P; Andersen CB; Willcox N; Coyle AJ; Holmdahl R; Kamradt T; Fugger L
    J Immunol; 2004 Dec; 173(11):7037-45. PubMed ID: 15557201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide-induced suppression of collagen-induced arthritis in HLA-DR1 transgenic mice.
    Myers LK; Sakurai Y; Tang B; He X; Rosloniec EF; Stuart JM; Kang AH
    Arthritis Rheum; 2002 Dec; 46(12):3369-77. PubMed ID: 12483744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analog peptides of type II collagen can suppress arthritis in HLA-DR4 (DRB1*0401) transgenic mice.
    Sakurai Y; Brand DD; Tang B; Rosloniec EF; Stuart JM; Kang AH; Myers LK
    Arthritis Res Ther; 2006; 8(5):R150. PubMed ID: 16982003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineered regulatory T cells coexpressing MHC class II:peptide complexes are efficient inhibitors of autoimmune T cell function and prevent the development of autoimmune arthritis.
    Qian Z; Latham KA; Whittington KB; Miller DC; Brand DD; Rosloniec EF
    J Immunol; 2013 Jun; 190(11):5382-91. PubMed ID: 23630354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visualization and phenotyping of proinflammatory antigen-specific T cells during collagen-induced arthritis in a mouse with a fixed collagen type II-specific transgenic T-cell receptor β-chain.
    Merky P; Batsalova T; Bockermann R; Dzhambazov B; Sehnert B; Burkhardt H; Bäcklund J
    Arthritis Res Ther; 2010; 12(4):R155. PubMed ID: 20682070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collagen-induced arthritis mediated by HLA-DR1 (*0101) and HLA-DR4 (*0401).
    Rosloniec EF; Whittington KB; He X; Stuart JM; Kang AH
    Am J Med Sci; 2004 Apr; 327(4):169-79. PubMed ID: 15084912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of glycosylation on HLA-DR1-restricted T cell recognition of type II collagen in a mouse model.
    von Delwig A; Altmann DM; Isaacs JD; Harding CV; Holmdahl R; McKie N; Robinson JH
    Arthritis Rheum; 2006 Feb; 54(2):482-91. PubMed ID: 16447222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell receptors recognizing type II collagen in HLA-DR-transgenic mice characterized by highly restricted V beta usage.
    He X; Rosloniec EF; Myers LK; McColgan WL; Gumanovskaya M; Kang AH; Stuart JM
    Arthritis Rheum; 2004 Jun; 50(6):1996-2004. PubMed ID: 15188377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen.
    Rosloniec EF; Whittington KB; Zaller DM; Kang AH
    J Immunol; 2002 Jan; 168(1):253-9. PubMed ID: 11751969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen.
    Rosloniec EF; Brand DD; Myers LK; Whittington KB; Gumanovskaya M; Zaller DM; Woods A; Altmann DM; Stuart JM; Kang AH
    J Exp Med; 1997 Mar; 185(6):1113-22. PubMed ID: 9091584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of macropinocytosis blocks antigen presentation of type II collagen in vitro and in vivo in HLA-DR1 transgenic mice.
    von Delwig A; Hilkens CM; Altmann DM; Holmdahl R; Isaacs JD; Harding CV; Robertson H; McKie N; Robinson JH
    Arthritis Res Ther; 2006; 8(4):R93. PubMed ID: 16704744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of gamma delta T cells in murine collagen-induced arthritis.
    Peterman GM; Spencer C; Sperling AI; Bluestone JA
    J Immunol; 1993 Dec; 151(11):6546-58. PubMed ID: 8245484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunopathogenesis of collagen arthritis.
    Brand DD; Kang AH; Rosloniec EF
    Springer Semin Immunopathol; 2003 Aug; 25(1):3-18. PubMed ID: 12904888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of T cell phenotype and function in a double transgenic (collagen-specific TCR/HLA-DR1) humanized model of arthritis.
    Tang B; Kim S; Hammond S; Cullins DL; Brand DD; Rosloniec EF; Stuart JM; Postlethwaite AE; Kang AH; Myers LK
    Arthritis Res Ther; 2014 Jan; 16(1):R7. PubMed ID: 24405551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of early changes in autoimmune T cell phenotype and function following intravenous administration of type II collagen in a TCR-transgenic model.
    Brand DD; Myers LK; Whittington KB; Latham KA; Stuart JM; Kang AH; Rosloniec EF
    J Immunol; 2002 Jan; 168(1):490-8. PubMed ID: 11751997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-10-deficient B10.Q mice develop more severe collagen-induced arthritis, but are protected from arthritis induced with anti-type II collagen antibodies.
    Johansson AC ; Hansson AS; Nandakumar KS; Bäcklund J; Holmdahl R
    J Immunol; 2001 Sep; 167(6):3505-12. PubMed ID: 11544344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.